Hot Features
Premium
Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 965,284 |
|
|||||
| News | - | ||||||
| Day High | 22.7599 | Low High |
|||||
| Day Low | 21.75 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc | ARWR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.28 | -1.24% | 22.33 | 16:00:50 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 22.52 | 21.75 | 22.7599 | 22.33 | 22.61 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,467 | 965,284 | US$ 22.18 | US$ 21,413,822 | - | 20.67 - 42.48 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:00:50 | formt | 500 | US$ 22.33 | USD |
Arrowhead Pharmaceuticals (ARWR) Options Flow Summary
Arrowhead Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.77B | 123.90M | - | 240.74M | -205.28M | -1.66 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Arrowhead Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARWR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 25.34 | 25.50 | 21.75 | 23.37 | 992,783 | -3.01 | -11.88% |
| 1 Month | 28.16 | 29.08 | 21.75 | 25.61 | 801,759 | -5.83 | -20.70% |
| 3 Months | 33.67 | 36.72 | 21.75 | 30.12 | 1,284,922 | -11.34 | -33.68% |
| 6 Months | 26.03 | 39.83 | 20.67 | 29.75 | 1,405,141 | -3.70 | -14.21% |
| 1 Year | 30.38 | 42.48 | 20.67 | 30.76 | 1,187,988 | -8.05 | -26.50% |
| 3 Years | 66.49 | 93.66 | 20.67 | 40.18 | 938,725 | -44.16 | -66.42% |
| 5 Years | 18.64 | 93.66 | 17.25 | 42.34 | 1,149,056 | 3.69 | 19.80% |
Arrowhead Pharmaceuticals Description
| Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease. |
